For over 100 years, the major public health advances have been the result of major scientific discoveries. The ways in which new medicines are discovered and manufactured is undergoing as major a ...

While there is a need for accuracy in pharmaceutical research, there is even a greater need for speed. Recent advancements in research have focused on methods for maximizing speed while still allowing ...

Pharmaceutical science has always demanded precision. Small differences in a product can have major consequences, and identifying or preventing these differences often requires extensive and ...

Eppendorf is launching the new Centrifuge 5811 R,a refrigerated, multipurpose benchtop centrifuge designed to support a wide range of laboratory workflows. It builds on the proven performance and ...

The modern landscape of biopharmaceutical manufacturing is dominated by the rapid introduction of single-use technologies (SUT) and their associated components. Highly complex and sophisticated ...

Cipla Limited (BSE: 500087; NSE: CIPLA) (“Cipla”) and Sino Biopharmaceutical Limited (HKEX: 1177) (“SBP Group”) today announced that SBP Group’s subsidiary, Chia Tai Tianqing Pharmaceutical Group Co., ...

In advanced biopharmaceutical production, the purity of a product and the need for a material to be chemically compatible and compliant with regulations make gaskets essential. Of the materials used ...

In modern-day chemical manufacturing for pharmaceuticals and specialty chemicals, there are certain chemical intermediates that continue to remain important. One such important chemical is ...

Automation of sample preparation has become the most significant advancement to the workflow of contemporary laboratories across pharmaceutical research and development (R&D), clinical diagnostics, ...

In biopharma manufacturing, Single-Use Technology (SUT) has allowed for much greater flexibility and responsiveness. But, this comes with significant cost. Loss of integrity with any of the bags used ...

For almost 20 years, custom medicine’s potential for success has been driven by the ability to potentially identify molecular signatures for a disease’s etiology instead of population-based markers.

The pharmaceutical, laboratory, and analytical industries are entering a defining phase where scientific rigor, technological intelligence, and regulatory expectations are converging like never before ...